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Abstract 
Mark R. Jezyk 
Structural Characterization of the Regulation of PLC-β2 
(Under the direction of Dr. John Sondek) 
 
The phospholipase C (PLC) family of enzymes mediates signal transduction 
events initiated at the cell surface by a myriad of receptors.  When activated by signaling 
pathways initiated by cell surface receptors, PLC enzymes catalyze the hydrolysis of the 
minor membrane lipid, phosphatidyl inositol (4,5) bis-phosphate into the second 
messengers, diacylglycerol and inositol (1,4,5) tris-phosphate.  These second messengers 
then stimulate the activity of protein kinase C and the release of intracellular calcium 
levels to regulate a vast array of cellular responses.  The PLC family of enzymes is 
composed of six subfamilies all containing a conserved core architecture.  This structural 
core is elaborated by various accessory domains, which facilitate the binding of activators 
and confer tight and specific regulation of PLC activity downstream of diverse signaling 
cascades.  To gain an understanding of the molecular mechanisms of such regulation we 
have determined the structures of the conserved core of PLC-β2 in the absence and 
presence of its activator, the small GTPase, Rac1.  These structures and the 
accompanying biochemical characterization reveal the overall organization of the enzyme 
and elucidate several mechanisms of its activation.  The work presented here greatly 
expands the understanding of PLC regulation and builds the foundation for further work 
aimed at identifying the physiological role of PLC signaling cascades.
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I 
Introduction 
The responses of multiple families of cell surface receptors are mediated through 
stimulation of PLC enzymes and their corresponding phospholipase activities1.  
Phospholipase C isozyme families all catalyze the hydrolysis of the phospholipid, 
phosphatidyl inositol (4,5) bis-phosphate (PtdIns(4,5)P2) into two vital second messenger 
molecules. The phospholipid headgroup is cleaved from the membrane anchored lipid tail 
of PtdIns(4,5)P2 to form soluble inositol (1,4,5) tris-phosphate and the membrane 
associated molecule, diacylglycerol.  These two molecules act downstream of 
phospholipase C to increase the cellular concentration of calcium by triggering the 
release of intracellular calcium stores and to modulate the activity of various protein 
kinase C isoforms.  These two divergent pathways go on to regulate a multitude of 
physiological effects initiated by activation cell surface receptors.  In addition to 
generating these second messengers, PLC isozymes also modify the amounts of their 
substrate, PtdIns(4,5)P2, in membrane microdomains2,3.  By regulating PtdIns(4,5)P2 
levels, PLC may modulate the activity of various proteins containing phospholipid 
binding domains to further control their downstream responses. 
 Studies of the activation events responsible for stimulation of PLC activity have 
historically been focused on regulation by receptor tyrosine kinases and seven 
transmembrane containing receptors coupled to heterotrimeric G proteins.  These systems 
directly couple the stimulation of various cell surface receptors by growth hormones, 
neurotransmitters, chemokines, and hormones to the activation of PLC enzymes.  
However, this paradigm has recently shifted due to the discovery of stimulation of certain 
PLCs by small GTPases of the Ras superfamily. 
 The PLC family of enzymes is divided into six subfamilies (β, γ, δ, ε, η, and ζ) 
based on sequence conservation (Figure 1)4.  All of these isozyme families catalyze the 
same hydrolytic reaction resulting in the regulation of second messenger signaling 
cascades.  However, various classes of signaling proteins regulate each subfamily.  This 
diverse regulation places PLC enzymes at nodes of signaling networks mediating 
crosstalk between a multitude of cellular inputs.   
Enzyme diversity within the PLC family 
 All PLC family members contain a conserved catalytic core of protein domains 
typified by the domain architecture of PLC-δ (Figure 2).  The phospholipase activity of 
PLC was originally attributed to two regions of the enzyme sharing the highest sequence 
conservation referred to as the X and Y boxes5.  Further biochemical characterization and 
sequence analysis has clarified the identities of the X and Y boxes.  The N-terminal half 
of the split catalytic TIM barrel forms the X region, while the C-terminal half along with 
a corresponding downstream stretch of conserved sequence forms the Y region.  This 
historical nomenclature has been dropped in most cases and the X and Y boxes 
commonly refer to just the N and C-terminal halves of the TIM barrel.  The conserved 
sequence C-terminal to the second half of the TIM barrel has since been identified as a 
C2 domain and is therefore omitted from the Y region.  The two halves of the catalytic 
domain are joined by a linker sequence that varies in both length and sequence 
composition across all PLC subfamilies.   
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 The remainder of the conserved domain architecture lies in the N-terminal region 
of PLC before the catalytic domain.  Here the sequence encodes a pleckstrin homology 
domain followed by a series of four EF hands.  While the structural motifs of these 
domains are predicted to be the same across the various subfamilies of PLC enzymes, 
their sequences are poorly conserved.   
 Various regulatory domains further elaborate the conserved core architecture of 
PLC enzymes.  These domains mediate interactions with a wide variety of upstream 
regulators of phospholipase activity and in the case of PLC-ε, modulate the activation of 
downstream effectors6.   
 The PLC-β isozyme family is characterized by a long sequence extending from 
the C-terminus of the C2 domain.  This region is composed of a flexible linker followed 
by a domain known to form an atypically long three helix bundle7.  This domain has been 
previously shown to mediate dimerization and stimulation of PLC-β2 by Gαq as well as 
to bind to and accelerate the intrinsic GTP hydrolysis of Gαq7-10. 
 PLC-γ isozymes also contain accessory domains in addition to their conserved 
catalytic core.  Within the linker of the catalytic TIM barrel of PLC-γ, lie four domains 
known to mediate protein binding events11.  The domain architecture of the XY linker is 
capped on either end by the presence of two halves of a split PH domain.  Following the 
N-terminal half of the PH domain are two SH2 domains and an SH3 domain.  These 
inserted protein modules mediate the interactions of PLC-γ with various regulators 
reviewed in great detail elsewhere1.   
 Lastly, the recently discovered PLC-ε is the largest member of the PLC family.  It 
contains a cystine rich region, followed by a Cdc25 or RasGEF domain known to 
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facilitate exchange on Ras superfamily GTPases.  In addition, a pair of tandem Ras 
associating domains known to bind directly to Ras GTPases caps the conserved core 
domain architecture of PLC-ε12.   
 Although sequence analysis and biochemical characterization of several of these 
accessory domains have provided many details concerning the regulation of PLC 
enzymes, a complete understanding of their interactions remains lacking.  Further 
structural analyses are required to elucidate the exact mechanisms of regulatory 
interactions with PLC family members and provide the tools to dissect their effects on 
cellular processes. 
 
Structural characterization of PLC-δ  
 Two crystal structures determined in the late 1990s provided the foundation for a 
structural understanding of the conserved core domain architecture of PLC family 
members13,14.  The structure of a high affinity complex of the N-terminal pleckstrin 
homology domain of PLC-δ1 and the soluble headgroup of its substrate, phosphatidyl 
inositol (4,5) bis-phosphate was determined at near atomic resolution.  The remainder of 
the conserved core of PLC-δ spanning from the EF hand domain to the end of the C2 
domain was also determined.  Taken together, these two structures depict a domain 
organization consisting of a tightly packed catalytic core made up of the EF hands, 
catalytic TIM barrel, and the C2 domain connected by a flexible linker to the PH domain. 
The flexible association of the PH domain with the remainder of the enzyme provides 
clues as to how it regulates the activity of the phospholipase.  Together these two crystal 
structures provided nearly all of the information known about the molecular mechanisms 
of PLC catalysis and regulation.  However, many questions remained.  How is specific 
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regulation of other PLC family members downstream of cell surface receptors achieved?  
Where do the binding sites for Gαq and Gβγ occur in PLC-β family members?  How 
does binding of these regulatory proteins stimulate the activity of the enzyme?  Does the 
recent discovery of stimulation of PLC-β isozymes by small GTPases offer novel modes 
of enzyme regulation to consider or does it reinforce previous models of PLC regulation?  
The structural determination and biochemical characterization of other PLC family 
members and their interacting partners is needed to provide answers to these questions.  
Comparison of these structures with those of PLC-δ will yield valuable insight into the 
regulatory mechanisms of PLC activation and the coordination of the enzyme’s activity 
within complex signaling cascades.   
 The crystal structure of the N-terminal PH domain of PLC-δ displays the 
canonical PH domain fold consisting of a seven stranded β-sandwich capped by the 
presence of a C-terminal helix14.  The soluble headgroup, Ins(1,4,5)P3, of the substrate of 
PLC-δ, PtdIns(4,5)P2, binds to loops formed between the strands of the β-sandwich 
facing the N-terminus of the capping helix.  This region of the PH domain is 
characterized by a highly electropositive electrostatic potential known to mediate 
phospholipid binding.  The sidechains of the basic residues Lys 30, Lys 32, Arg 40, and 
Lys 57 found within these loops contribute to the electroposititve character of the PH 
domain and form specific interactions with the phospholipid headgroup.  It has been 
proposed that the ability of the PH domain of PLC-δ to bind the enzyme’s catalytic 
substrate may offer a mechanism for enzymatic regulation by recruiting the 
phospholipase to pools of its substrate and facilitating processive catalysis known as 
“membrane scooting”15.  However, this mechanism appears to be unique to PLC-δ.  The 
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basic residues responsible for PtdIns(4,5)P2 binding are poorly conserved across other 
PLC family members.  Biophysical characterization of PLC-β isozymes has 
demonstrated that although the PH domain binds to lipid bilayers16,17, it does not bind to 
phospholipids with high affinity or specificity18.  However, this data has conflicted with 
the findings of in vivo experiments, which show that the PH domain of PLC-β1 is 
transiently localized to the plasma membrane by PtdIns(3)P19.  PLC-γ isozymes have 
been shown to preferentially bind PtdIns(3,4,5)P3 as opposed to the substrate of the 
enzyme, PtdIns(4,5)P2 and PLC-ε family members lack a highly polarized electrostatic 
potential required for phospholipid binding.   
 The second structure of PLC-δ displayed the remaining domains of the catalytic 
core of the enzyme13.  The PH domain of PLC-δ was omitted from the construct used for 
structure determination due to the inherent mobility of the domain relative to the catalytic 
core, which inhibited crystallization.  The N-terminus of the structure starts with an 
incomplete series of EF hands.   The first lobe of the EF hand domain consisting of two 
helix-loop-helix motifs was incompletely modeled due to its high mobility within the 
crystal lattice.  Taken in the context with the intrinsic flexibility of the PH domain, this 
observation suggests that the EF hands may form a flexible linker joining the PH domain 
to the remainder of the enzyme and allowing for relative motion of the two regions. 
 The catalytic TIM barrel follows the EF hands of PLC-δ in the crystal structure.  
It is tightly packed between the EF hands and the C-terminal C2 domain, burying 
extensive surface area and forming a rigid module.  The TIM barrel and C2 domain are 
highly conserved throughout the PLC family and together have been historically labeled 
the XY region.  A flexible linker separates the two halves of the split TIM barrel.  The N-
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terminal half is known to comprise the X region and the C-terminal half along with the 
C2 domain was originally labeled the Y region.  Currently, this nomenclature has been 
modified so that the two halves of the split TIM barrel are referred to as the X and Y 
regions, while the C2 domain has been established as an independent domain.  The TIM 
barrel possesses a large ovoid indentation capable of binding the headgroups of substrate 
molecules.  The structure reveals that specific residues within this binding pocket 
coordinate the position of the phospholipid and facilitate its hydrolysis.  In addition, large 
loops surrounding the substrate-binding site are highly hydrophobic and serve to 
penetrate into lipid membranes allowing access of PtdIns(4,5)P2 to the binding pocket20.  
One loop that was not visible in the structure was the linker between the X and Y regions 
of the protein.  This linker is highly variable throughout all PLC enzymes and its function 
is not currently known.  Several studies have identified this region as being important for 
modulating the activity of PLC isozymes, but further experiments are required to 
elucidate the nature of this modulation21,22.  The residues involved in substrate binding 
and catalysis are highly conserved across the PLC family indicating that the catalytic 
mechanism of all PLCs is identical.  Regions of PLC outside of the catalytic TIM barrel 
must therefore confer regulation of phospholipase activity downstream of specific signal 
transduction pathways. 
 Finally, the C2 domain caps the structure of the core architecture of PLC-δ.  All 
PLC isozymes are modulated by calcium, with PLC-δ demonstrating the most potent 
activation by the ion.  A large part of this activation is due to the C2 domain’s ability to 
bind several calcium ions.  The determinants for calcium binding within this region have 
been extensively characterized by both biochemical and structural analysis23.  Loops of 
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the C2 domain commonly referred to as “jaws” bind calcium ions through electrostatic 
interactions with acidic residues.  The ability of this domain to bind calcium has been 
shown cause the C2 domain to localize to membrane surfaces via a cation-mediated 
mechanism24.  However, this mechanism is not conserved for other PLC subfamilies.  
Specifically, PLC-β isozymes lack the acidic residues required for calcium binding.  
However, other mechanisms may exist that facilitate the recruitment of the C2 domain of 
these isozymes to lipid membranes.  The C2 domain of PLC-β family members may bind 
directly to membrane lipids or may be recruited through interactions with membrane-
localized proteins.  Further studies are needed to identify the membrane associating 
functions of this highly conserved domain across all PLC families. 
 Together, the two structures of PLC-δ portray an enzyme perfectly evolved to 
bind phospholipid-containing membranes.  Each domain of PLC-δ forms a contact point 
with the membrane surfaces.  The highly coordinated binding of PLCs to substrate-
containing membranes must therefore be taken into consideration when analyzing any 
aspect of PLC regulation.  This observation has direct consequences for all models of 
PLC regulation based on membrane recruitment through lipid and protein interactions.   
 
Regulation of PLC isozymes by heterotrimeric G proteins 
Seven transmembrane spanning receptors relay signals from the extracellular 
environment to the cell interior by coupling to heterotrimeric G proteins.  G protein 
coupled receptors (GPCRs) comprise one of the largest protein families in the human 
genome.  A wide variety of ligands including hormones, neurotransmitters, growth 
factors, and chemokines activate GPCRs to trigger myriad physiologic responses25.  
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GPCRs account for the majority of drug targets in the human genome and also receive 
the sensory inputs for everything humans smell, taste, and see. 
Heterotrimeric G proteins couple to GPCRs in their inactive state.  They consist 
of an α, β, and γ subunit.  Gα subunits are grouped into three families (Gαi/o, Gαq, Gαs, 
and Gα12/13) based on sequence conservation.  Similarly, five genes of Gβ subunits and 
thirteen of Gγ are found in the human genome and expressed in various combinations.  In 
their inactive conformation, heterotrimeric G proteins bind the guanine nucleotide, GDP, 
through interactions with the α subunit.  Gα possesses switch regions that are involved in 
binding nucleotide and undergo conformational changes upon activation.  Upon agonist 
binding, the seven membrane spanning regions of GPCRs propagate conformational 
changes across the plasma membrane to the heterotrimeric G protein residing on the 
cytoplasmic face of the receptor.  The receptor then activates the G protein causing 
conformational changes in the switch regions of the α subunit thereby releasing GDP and 
causing the β and γ subunits to dissociate as an obligate dimer.   The α subunit then binds 
GTP due to its higher molar concentration within the cell relative to GDP.  The activity 
of Gα is turned off by the intrinsic hydrolysis of the terminal phosphate of GTP.  The 
speed of this rate-limiting step is dramatically enhanced by the activity of GTPase 
accelerating proteins (GAPs).  Once dissociated the Gα and Gβγ subunits independently 
regulate various cellular functions by signaling to downstream effectors. One such 
downstream effector of both Gα and Gβγ is the enzyme PLC-β (Figure 3). 
 
Regulation of PLC-β  by Gαq subunits 
9
 Heterotrimeric G protein subunits of the Gαq family were initially shown to 
stimulate the phospholipase activity of PLC-β isozymes26-28.  Further characterization of 
the interactions of these proteins with PLC-β isozymes revealed that their capacity to 
stimulate PLC activity was mediated through direct binding to the enzymes.  The affinity 
of Gαq subunits for PLC-β isozymes was also demonstrated to be dependent on the 
presence of GTP, indicating that the G proteins bind PLC-β preferentially in their 
activated state.  Therefore, by definition, PLC-β is a genuine effector of Gαq subunits.  
Gαq family members bind to all four PLC-β isozymes with varying affinities1.  Gαq 
binds with low nanomolar affinity and activates PLC-βs 1 and 3 and to a lesser extent to 
PLC-β2.  The regions of PLC-β isozymes responsible for binding Gαq family members 
have been delineated to the C2 and C-terminal domains.  Truncation analysis of PLC-β 
family members has indicated that the C-terminal region of PLC-β isozymes required for 
Gαq binding and activation begins at residue 84529.  This region of the protein 
demonstrates considerable inherent flexibility relative to the catalytic core of PLC-β 
enzymes and therefore, the crystal structure of the C-terminal domain was determined 
independently.  The C-terminal domain of PLC-β family members contains several 
highly basic patches and adopts an unusually large coiled coil domain7.  The basic 
regions of this domain are responsible for the binding of Gαq, and although the 
interaction surface has been predicted by protein docking, the exact structural 
requirements of such an interaction interface remain unknown. Despite the ability of Gαq 
to stimulate the intrinsic enzymatic activity of PLC-β, no interactions of the G protein 
with the catalytic domain of PLC-β isozymes have been discovered.  Direct interactions 
between Gαq and the TIM barrel of PLC-β would not be required for stimulation of the 
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enzyme due to the membrane-bound nature of the Gαq subunits.  The amino terminal 
ends of Gα subunits possess sites for the covalent modification of the protein by the 
addition of palmitoyl moieties.  These lipid modifications anchor Gα subunits to the 
plasma membrane even after dissociation of the G protein from its membrane-bound 
receptor.  Therefore, following activation by a receptor, Gαq can stimulate PLC-β 
activity by recruiting the enzyme to the plasma membrane where the lipid substrate of the 
enzyme resides. 
 In addition to possessing the ability to bind Gαq, the C-terminal helical domain of 
PLC-β also mediates various other regulatory mechanisms responsible for phospholipase 
signaling.  As stated above, the regions of PLC-β believed to be responsible for binding 
and activation by Gαq are conserved throughout the PLC-β family and characterized by a 
highly basic electrostatic potential.  This electropositive character also facilitates the low 
affinity association of PLC-β enzymes with acidic lipids of the plasma membrane.  By 
weakly associating with substrate-containing membranes, PLC-β remains poised for 
rapid activation by membrane-anchored modulators such as Gαq30.  The C-terminal 
domain has also been shown to mediate homo- and hetero-dimerization of PLC-β 
isozymes.  This dimerization is clearly seen in the crystal structure of avian PLC-β where 
two monomers of the C-terminal domain form a complex that buries approximately 3200 
Å2 of solvent accessible surface area, indicative of a physiologically relevant interaction7.  
This structural data is further supported by the co-migration of two monomers of the C-
terminal domain as a dimer using gel exclusion chromatography.  Although the evidence 
clearly indicates that PLC-β isozymes exist as dimers, the physiological ramifications of 
such dimerization remain unknown.   
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 Lastly, the rapid activation of PLC-β isozymes by Gαq can also be attributed to a 
reciprocal regulation of the G protein by PLC-β itself.   Studies have demonstrated that 
PLC-β robustly stimulates the intrinsic GTPase activity of Gαq8,9.  Furthermore, this 
GAP activity has been delineated to the C-terminal domain of PLC-β responsible for 
Gαq binding10.  In fact, the C-terminal domain of PLC-β was the first protein 
demonstrated to possess GAP activity towards an α subunit of heterotrimeric G proteins.  
Detailed enzymatic analysis of Gαq has revealed that the G protein undergoes numerous 
rounds of GTP loading and hydrolysis while being activated by a receptor and binding 
PLC-β31.  Such cycling facilitated by the GAP activity of PLC-β serves to expedite rapid 
signal turnover and reduce response times for GPCR stimulated signaling cascades.    
 
Regulation of PLC-β  by Gβγ  subunits 
 Gβγ subunits of heterotrimeric G proteins also markedly stimulate the activity of 
PLC-β isozymes32-34.  Specifically, Gβγ binds to PLC-βs 1-3 and with the tightest 
association and most robust stimulation occurring on PLC-β234.  Although the affinities 
of Gβγ subunits for PLC-β isozymes are lower than those of Gαq, the maximal activation 
of phospholipase activity observed for the two G proteins is comparable.  Gβγ subunits 
are considered to be a more general stimulus for PLC-β2 activity than Gαq due to the 
redundancy of Gβγ in heterotrimeric G proteins coupled to GPCRs.  In fact, individual 
receptors may couple to both Gαq and Gβγ subunits simultaneously allowing for 
increased stimulation of the capacity of PLC-β to hydrolyze substrate and generate 
second messenger molecules.  Like Gαq, Gβγ subunits are covalently modified by lipid 
moieties.  Specifically, the γ subunit is isoprenylated at the cystine residue of a CAAX 
12
motif found at the C-terminus of the protein.  This lipid modification anchors Gβγ to the 
plasma membrane even after dissociation from a GPCR and Gα subunit.  Therefore, the 
mechanism of activation of PLC-β as an effector of Gβγ subunits is hypothesized to be 
similar to that of Gαq.   Gβγ is believed to recruit PLC-β to substrate-containing 
membranes to dramatically increase the local concentration of substrate proximal to the 
enzyme’s catalytic binding pocket.  However, the exact determinants for Gβγ binding to 
PLC-β remain unknown.  If by interacting with PLC-β, Gβγ perturbs the binding site of 
the enzyme, allosteric regulation of phospholipase activity as well as membrane 
localization may be attributed to Gβγ subunits.   
 The region of PLC-β responsible for the binding of Gβγ subunits remains in 
dispute.  The majority of evidence indicates that the pleckstrin homology domain of PLC-
β isozymes confers Gβγ binding and stimulation.  This interaction is supported by the 
observation that various PH domains are known to mediate interactions between Gβγ and 
effectors35.  Deletion of the PH domain of PLC-β completely eliminates Gβγ stimulated 
phospholipase activity demonstrating that it is essential for activation of the enzyme.  
Analysis of chimeric PLC proteins also supports this hypothesis36.   Studies where the PH 
domains of PLC-β2 and PLC-δ were swapped indicated that the PH domain of PLC-β2 
was sufficient to confer Gβγ stimulation of phospholipase activity on PLC-δ.  
Conversely, when the PH domain of PLC-β2 was replaced by that of PLC-δ, the resulting 
enzyme lost all responsiveness to Gβγ.  Furthermore, the hypothesis that Gβγ subunits 
stimulate the catalytic activity of PLC-β by recruiting the enzymes to the plasma 
membrane was reinforced by the observation that the PH domain of PLC-β1 localized to 
the membrane upon binding to Gβγ16. 
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 However, other regions of PLC-β isozymes have emerged as potential candidates 
for Gβγ binding sites.  Mutational analysis of a short sequence in the Y box of the 
catalytic TIM barrel of PLC-β2 proximal to the XY linker was mapped as a binding site 
for Gβγ37.  This data suggests a mechanism of activation in agreement with the 
hypothesis that Gβγ may allosterically modify the substrate-binding site of PLC-β 
isozymes to stimulate their enzymatic activity.  Further biochemical and structural studies 
are needed to determine whether Gβγ subunits bind to multiple sites on PLC-β and if 
multiple regulatory mechanisms are utilized by G proteins to facilitate PLC-β activation.  
The structures presented here suggest that the catalytic domain of PLC-β2 may be basally 
inhibited by intramolecular interactions between the catalytic pocket of the TIM barrel 
and the XY linker offering the intriguing possibility of a stimulatory mechanism whereby 
Gβγ must bind to the XY linker in order to relieve steric occlusion of the substrate-
binding site.  The enigma of Gβγ binding to PLC-β is especially intriguing when 
analyzed within the context of PLC-β dimerization.  Molecules of PLC-β may in fact 
function as signaling scaffolds by coordinating multiple stimulatory inputs from both G 
protein α and βγ subunits allowing for the convergence of multiple receptor initiated 
signaling events. 
 
Activation of PLC isozymes by small GTPases 
 The Ras superfamily of GTPases is comprised of approximately 150 proteins 
sharing similar sequence and structural characteristics and divided into five distinct 
families; Arf, Rab, Ras, Ran, and Rho38.  Proteins of these subfamilies are most well 
known for their functions as oncogenic products involved in the processes of cell 
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transformation, tumor development, and metastasis.  The Rho subfamily has garnered 
particular attention due to the ability of its member proteins to modulate the remodeling 
of the actin cytoskeleton required for cell detachment and migration39.   The Rho 
subfamily contains three prototypical members, Rac, Cdc42, and RhoA, which are best 
known for facilitating the formation of the actin rich structures lamellipodia, actin 
microspikes and stress fibers, respectively.  These proteins share overlapping groups of 
effectors and their signaling pathways are diverse, highly redundant, and complexly 
integrated.   
 Small GTPases share structural and functional similarity with Gα subunits of 
heterotrimeric G proteins.  In their inactive form, they bind the nucleotide, GDP.  Upon 
activation, switch regions similar to those of Gα undergo conformational changes that 
result in the release of GDP and the subsequent loading of GTP.  GTP stabilizes the 
switch regions in their active conformations, where they are able to interact specifically 
with effector proteins.   
 Despite these similarities, the activation of small GTPases occurs in a distinct 
manner from that of heterotrimeric guanine nucleotide binding proteins.  Rho family 
GTPases do not interact directly with cellular receptors.  Instead, proteins known as 
guanine nucleotide exchange factors (GEFs) catalyze the release of GDP and the uptake 
of GTP40.  However, this activation is still dependent on upstream receptor signaling 
events.  Many receptor tyrosine kinases potently stimulate the activation of small 
GTPases upon agonist binding.  Integrins, which mediate cell to cell contacts at the 
plasma membrane also signal directly to various small GTPases.  In addition, GPCRs 
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also indirectly regulate the activity of Rho family GTPases through the actions of GEFs 
activated by both Gα and Gβγ subunits41-44. 
 Like that of heterotrimeric G proteins, the duration of small GTPase signaling 
events is also controlled by GAPs, which facilitate the hydrolysis of the γ-phosphate of 
GTP, returning the GTPase to its inactive, GDP-bound state.  Once inactive, the release 
of GDP independent of the action of GEFs is prevented by proteins known as guanine 
nucleotide dissociation inhibitors (GDIs).  However, the mechanisms for GDI binding are 
not perfectly understood as multiple studies have demonstrated the ability of Rho GDIs to 
bind to small GTPases in their activated, GTP-bound states. 
 Recently, several small GTPases have been identified as binding partners and 
activators of PLC enzymes.  These interactions suggest that complex interplay between 
heterotrimeric G protein and small GTPase signaling cascades occurs to intricately 
coordinate the generation of second messengers with a multitude of upstream regulators 
and thereby control a vast array of physiological processes.  PLC enzymes therefore 
function as critical signaling nodes required for the proper processing of information 
pathways within a cell. 
 
Regulation of PLC-β2 by Rac 
 Until recently, the study of PLC-β regulation was predominantly focused on 
identifying and characterizing the interactions of heterotrimeric G protein subunits and 
PLC-βs 1-4.   This focus shifted dramatically only a few years ago with the identification 
of small GTPases of the Rho subfamily interacting with PLC-β isozymes (Figure 4)45.   
Cytosolic fractions from bovine neutrophils were shown to contain a heterodimeric 
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complex that was capable of stimulating the enzymatic activity of PLC-β2 in a GTP-
dependent manner.  The stimulation of PLC-β2 activity was attributed to a novel mode of 
regulation independent of Gαq activation by the observation that PLC-β2 lacking the 
carboxy-terminal domain required of Gαq binding was still stimulated by the soluble 
factor.  When purified, the stimulating factor was identified as a heterodimeric complex 
formed between a 23 kDa and a 26 kDa protein46.  Protein sequencing and reactivity to 
antisera immunoreactive to RhoA and Cdc42 identified the 23 kDa protein as being 
similar to small GTPase, RhoA.  Protein sequencing of the 26 kDa protein identified it as 
the Rho family GDI, LyGDI.  Depletion of Rho GTPases from the soluble preparation by 
exposure to immobilized LyGDI eliminated the GTP stimulated activity of PLC-β2, 
therefore indicating that the stimulating factor was in fact the GTPase. 
 Further studies demonstrated that the prototypical Rho family GTPases, Cdc42, 
Rac1, and Rac2, stimulated the activity of PLC-β2 while RhoA had no effect47.   Cdc42 
was the least potent and efficacious of the three GTPases at stimulating phospholipase 
activity, while Rac 1 and 2 showed similar activation.  Similar studies using 
cotransfection of activated GTPases and PLC-β isozymes confirmed these findings18,48.  
Furthermore, membrane localization of the small GTPases due to C-terminal lipid 
modification was essential for stimulation PLC-β2 activity49.   This observation 
suggested that Rac was functioning to recruit the soluble enzyme, PLC-β2, to the plasma 
membrane50.  The binding of the GTPases to PLC-β2 was further delineated by mutation 
of key residues located in the effector-binding site of Cdc42, known to be responsible for 
mediating GTPase/effector interactions.  The GTP dependence of the interaction between 
the GTPase and the phospholipase as well as the resultant loss of stimulation upon 
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disruption of the effector-binding site, demonstrated that Rac binds PLC-β2 as a genuine 
effector.  Furthermore, enzymatic assays and measurement of direct interactions using 
surface plasmon resonance showed that Rac demonstrated considerable PLC-β isozyme 
specificity18.  Activated Rac bound to and stimulated PLC-β2 with the highest affinity, 
PLC-β3 to a lesser extent, and PLC-β1 negligibly.  The specificity of PLC-β2 for the 
entire family of Rho GTPases was then tested.  In direct binding assays, only Rac 1-3 
bound to PLC-β2 in a nucleotide-dependent manner. 
 The region of PLC-β2 responsible for mediating interactions with Rac was further 
delineated by chimeric analysis of the enzyme51.  The PH domains of PLC-β1 and β2 
were swapped revealing that the PH domain of PLC-β2 was capable of conferring Rac 
stimulated phospholipase activity on PLC-β1.  However, the converse experiment where 
the PH domain of PLC-β2 was replaced with that of PLC-β1 resulted in complete 
ablation of Rac stimulated PLC-β2 activity.  Furthermore, the purified PH domain of 
PLC-β2 was sufficient to bind Rac1 in a GTP dependent manner as indicated by 
measurements of direct interactions analyzed by surface plasmon resonance18.  The role 
of the PH domain as a docking site for small GTPase regulators of PLC-β2 is similar to 
that hypothesized for Gβγ subunits.  In simple reconstitution assays, stimulation of PLC-
β2 activity by Gβγ and Rac appeared to be additive49.  Also, the structure-based 
biochemical characterization of the Rac/PLC-β2 interface presented in this work 
indicates that Rac and Gβγ bind to independent sites of the PH domain.  Therefore, the 
possibility exists that both molecules may stimulate the activity of PLC-β2 in coordinated 
signaling cascades.  Indeed, both Rac and Gβγ subunits are believed to activate PLC-β2 
through a similar mechanism.  Like heterotrimeric G protein subunits, small GTPases 
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possess lipid modifications that anchor them to the plasma membrane.  Activation of both 
proteins would therefore result in the recruitment of PLC-β2 to substrate-containing 
membranes.  Evidence for such a mechanism was provided by studies of the localization 
of GFP-tagged PLC-β2.   Upon coexpression with activated Rac1, GFP-tagged PLC-β2 
was removed from the cytosol and localized to the plasma membrane of live cells50.  
Whether endogenous PLC-β2 is localized in similar manner or more specifically to 
particular subcellular compartments remains to be ascertained.  However, such 
localization may significantly impact interplay between G protein and small GTPase-
mediated activation of PLC isozymes in a true physiological context.  It should also be 
noted that Rac has recently been shown to directly bind and stimulate the PLC family 
member, PLC-γ252.  This result adds to the already intricate complexity of PLC signaling.  
Future studies aimed at dissecting such complex signaling cascades are required to 
elucidate the physiological function of individual interactions and will significantly 
increase our understanding of PLC regulation. 
 
Interactions between small GTPases and PLC-ε 
 In addition to Rac mediated stimulation of PLC-β isozymes, the theme of small 
GTPases interacting with PLC family members has been dramatically elaborated by the 
recent identification of PLC-ε and its GTPase binding partners12,53,54.  Sequence analysis 
of PLC-ε isozymes identifies three known Ras GTPase interacting domains.  The 
RasGEF or Cdc25 domain is located N-terminal to the predicted PH domain of PLC-ε6.  
Also, two tandem Ras associating domains (RA1 and RA2) terminate the domain 
structure of PLC-ε.  Fragments of PLC-ε containing the RA1 and RA2 domains were 
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shown to bind H-Ras and Rap1a in a nucleotide-dependent manner12.  Mutations within 
H-Ras known to disrupt GTPase binding to RA domains resulted in diminished 
interactions with the C-terminus of PLC-ε.  Cotransfection of a constitutively active form 
of Ras with PLC-ε resulted in the drastic stimulation of PLC-ε phospholipase activity.  
Constitutively active H-Ras was also shown to recruit PLC-ε to the plasma membrane.  
The binding of H-Ras was further delineated to the RA domains by analysis of 
interactions between the GTPase and truncation mutants of PLC-ε lacking these domains.  
The ability of Ras GTPases to interact directly with the RA domains of PLC-ε provides a 
mechanism for cell surface receptors such as tyrosine kinases, found upstream of Ras 
signaling pathways, to stimulate the hydrolysis of PtdIns(4,5)P2 and the generation of 
second messengers. 
 Additional stimulation of PLC-ε by small GTPases was identified when 
cotransfection of the Rho family GTPases RhoA, B, and C with PLC-ε resulted in 
increased phospholipase activity55.  Rho-stimulated PLC-ε activity was maintained even 
after removal of both the RasGEF and tandem RA domains.  Direct regulation of PLC-ε 
by RhoA was confirmed by reconstitution experiments using a purified fragment of PLC-
ε spanning from the EF hands to the tandem RA domains.  Prenylated RhoA activated 
PLC-ε in a GTPγS-dependent fashion.  Cotransfection experiments in COS-7 cells as 
well as reconstitution experiments using purified proteins mapped the region of PLC-ε 
involved in RhoA activation to a 70 residue insert unique to the Y region of PLC-ε56-58.  
The activation of PLC-ε by Rho proteins is further supported by the stimulation of PLC-ε 
by Gα12 and Gα13.  Although these two G proteins upregulated the activity of PLC-ε, 
neither has been shown to directly bind to the phospholipase.  However, these G proteins 
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are known to activate a class of Rho specific GEFs are known as RhoGEFs41,43.  
Therefore, the regulation of PLC-ε by Gα12 and Gα13 is most likely indirectly mediated 
by activation of RhoA downstream of Gα12 and Gα13 coupled GPCRs59.   
 Both the interaction of H-Ras with the C-terminal RA domains of PLC-ε and that 
of RhoA with the 70 amino acid loop of the catalytic domain and their subsequent 
stimulatory effects on phospholipase activity reveal a role for upstream regulation of 
PLC-ε by the Ras superfamily of small GTPases.  In addition, PLC-ε may reciprocally 
stimulate the activity of small GTPases through activation of Ras family proteins its 
RasGEF domain.  Findings describing the downstream effects of PLC-ε on Ras GTPase 
signaling are beyond the scope of this work and have been comprehensively reviewed 
elsewhere4.   
Taken together with the work previously described implicating the Rho GTPase, 
Rac, in the regulation of PLC-β and γ isozymes, these observations reveal an emerging 
theme within phospholipase signaling where small GTPases form various interacting 
pairs with numerous PLC family members.  These regulatory interactions further 
complicate the already intricate regulation of PLC enzymes by classes of molecules as 
diverse as receptor tyrosine kinases and G protein coupled receptors (Figure 5).  The 
numerous interactions of regulatory modulators with PLC isozymes form a vast network 
of signaling pathways allowing for the crosstalk and coordination of various cascades 
downstream of cell surface receptors.  To gain an in depth understanding of the details of 
such a signaling network, it is necessary to identify all of the protein components of the 
network and elucidate the set of intermolecular interactions that they participate in.  Once 
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identified, these interactions must be biochemically and structurally characterized in 
order to provide the tools necessary for dissection of their relevant physiological roles. 
 
Regulation of PLC family members via the XY linker 
 As previously described, the catalytic TIM barrel of all PLC family members is 
highly conserved and divided into two sections known as the X and Y regions.  Between 
these two regions is a linker sequence that is highly variable in both length and 
composition.  The XY linker of PLC-δ is the shortest of all PLC enzymes, while the 
linkers of PLC-β and PLC-ε isozymes are approximately 100 and 200 residues, 
respectively1.  Members of the PLC-γ subfamily possess the longest XY linkers of all 
PLC enzymes at approximately 400 amino acids.  The extensive length of this linker 
sequence can be attributed to the presence of several domains within the sequence span of 
the TIM barrel11.  In addition to encoding the two halves of the split catalytic domain, the 
sequence of PLC-γ also contains two halves of a split PH domain proximal to the X and 
Y regions.  Three domains responsible for mediating intermolecular protein interactions 
lie between these two halves of the PH domain.  Specifically, two SH2 domains and an 
SH3 domain follow the N-terminal half of the split PH domain, before rejoining the C-
terminal half of the PH domain.  The analysis of the function of the XY linkers of all 
PLC family enzymes has largely been ignored, most likely due to their low sequence 
conservation and the absence of structural data describing their interactions.  However, 
several studies have implicated these regions in the regulation of phospholipase activity 
catalyzed by PLC family members.  Occlusion of the substrate-binding cavity of PLC 
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enzymes by the XY linker may provide a general mechanism for regulation of this class 
of enzymes.   
 The most well characterized role of the XY linker in regulating PLC activity is 
found in the PLC-γ family of enzymes.  The regulation of PLC-γ isozymes by tyrosine 
kinases has been reviewed extensively elsewhere1.  The split PH, SH2, and SH3 domains 
of the XY linker of these isozymes are all known to mediate intermolecular protein 
interactions.  Additionally, expression of PLC-γ lacking portions of the XY linker show 
increased specific activity60.  Furthermore, phosphorylation of Tyr 783 within the linker 
region of PLC-γ1 has been shown to intramolecularly bind to the C-terminal SH2 domain 
of the XY linker to stimulate phospholipase activity61.  This observation is consistent 
with a role of the XY linker of PLC-γ in inhibiting access of the phospholipase to 
substrate molecules. 
The XY linker of PLC-δ was not visible in the crystal structure of the catalytic 
core of the enzyme13.  This may be due to its ability to adopt various conformations that 
may sterically occlude the substrate-binding site.  However, studies describing 
proteolysis of the sequence between the X and Y regions of PLC-δ1 have indicated that 
the basal hydrolytic activity of the enzyme is increased upon proteolytic cleavage62.  This 
data suggests that the XY linker may in fact inhibit phospholipase activity by blocking 
access to the catalytic site of PLC-δ1.  In addition, the calcium binding protein 
calmodulin has been shown to interact with the linker of PLC-δ and to inhibit 
phospholipase activity suggesting that calmodulin may stabilize an inhibitory 
confirmation of the linker region in the vicinity of the substrate-binding pocket21. 
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 Similar results have been obtained for members of the PLC-β family of isozymes.  
Proteolysis of a construct of PLC-β2 lacking the C-terminal region responsible for Gαq 
binding removed the XY linker and increased the basal specific activity of the enzyme.  
Additionally, the proteolyzed enzyme demonstrated only a two-fold increase in 
phospholipase activity when stimulated by Gβγ despite reaching an equivalent level of 
maximal activation compared to wild type PLC-β222.  Peptides corresponding to the 
sequence of the XY linker have also been shown to enhance enzymatic activity of PLC-
β2 suggesting that they interfere with normal interactions of the linker with the catalytic 
site63.  The crystal structures presented in this work also confirm the hypothesis that the 
XY linker interacts with the binding site of PtdIns(4,5)P2 by sterically occluding the 
binding pocket of PLC-β2.  Removal of inhibition by the linker from the catalytic site of 
PLC-β2 may prove to be a vital mechanism for the regulation of PLC-β activity.  Gβγ 
provides a likely mediator of this mechanism.  If this hypothesis proves to be valid, it 
would indicate that Gβγ plays dual roles as a membrane localization signal and an 
allosteric modulator of PLC-β isozymes. 
Understanding of the intricate regulation of the entire family of PLC enzymes 
remains incomplete.  The extensive crosstalk and interplay of signaling pathways 
converging on PLC isozyme families further complicates this analysis.  However, 
identification of the relevant modulators of PLC activity and their interactions with 
individual phospholipase C proteins will vastly expand the current knowledge of such 
signaling networks.  It is clear that PLC enzymes function as signaling nodes in these 
networks and that to understand their roles in mediating cellular functions, it is necessary 
to elucidate the full complement of their interactions.  Once these interactions have been 
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biochemically and structurally characterized, we will then be able to dissect the roles they 
play in various physiological processes.  Until this is accomplished, predictions of vital 
cellular behaviors stemming from phospholipase signaling will remain enigmatic.  
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Figure 1
PLC enzyme diversity
Dendrogram based on sequence conservation showing the six PLC isozyme families
grouped by similarity on shared branches.  The conserved domain architecture of the
PLC family is indicated by similar coloring.  Diverse regulatory domains are depicted
as grey modules.   
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Figure 2
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Domain architecture of PLC isozyme families.
The conserved core architecture of the various PLC families is indicated schematically.
All PLC families with the exception of PLC-ζ share a common domain organization 
comprised of a PH domain, a series of EF hands, a catalytic TIM barrel known as the XY
box, and a C2 domain.  This domain architecture is further elaborated  by various
regulatory domains indicated in grey.  
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Figure 3
PLC-β
Heterotrimeric G proteins stimulate PLC-β isozymes.
Upon activation by GPCRs, Gαq and Gβγ heterotrimeric G protein subunits dissociate
and bind to downstream effectors.  Both subunits are capable of directly binding and
activating PLC-β isozymes.  In addition, PLC-β accelerates the intrinsic hydrolysis of
GTP by Gαq to return the α subunit to its inactive conformation.  
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Figure 4
PLC-β
The small GTPase, Rac, activates PLC-β. 
Upon activation by guanine nucleotide exchange factors, Rac binds GTP and
signals to downstream effectors.  Activated Rac has recently been shown to
directly bind to PLC-β2 and stimulate its phospholipase activity indicating that
it is a genuine Rac effector.  
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PLCs function as intricate signaling nodes.
A sampling of the complexity of PLC signaling pathways is depicted schematically.
PLCs mediate crosstalk between several cell surface receptor families.  Identification
of interacting partners and subsequent biochemical and structural characterization
is beginning to yield insights into the regulation of such signaling networks.
RGS RhoGEFs
30
  
 
 
 
II 
 
Crystal structure of the conserved core of phospholipase C-β2 
 
 
Mark R. Jezyk†, Stephanie N. Hicks‡, Jason T. Snyder‡, T. Kendall Harden‡,  
and John Sondek†‡* 
 
 
†Department of Biochemistry and Biophysics 
‡Department of Pharmacology 
*Lineberger Comprehensive Cancer Center 
The University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA 
Abstract 
Phospholipase C (PLC) enzymes constitute a diverse family of proteins that 
propagate signaling cascades downstream of cell surface receptors.  Activation of 
receptors by agonists such as growth factors, hormones, and neurotransmitters lead 
to the stimulation of the catalytic activity of PLC enzymes and the generation of 
second messenger molecules.  All PLC family members catalyze the hydrolysis of 
the phospholipid, phosphatidylinositol(4,5)bisphosphate, and produce the second 
messenger products, inositol(1,4,5)trisphosphate and diacylglycerol.  These two 
signaling molecules go on to control a vast array of cellular responses by regulating 
intracellular calcium levels and the activity of protein kinase C.  PLCs possess a 
conserved core architecture often elaborated by additional domains that confer 
specificity to the regulation of the isozymes within each family.  Here we present the 
high-resolution crystal structure of the conserved core of PLC-β2.  It is the first 
intact structure of the conserved core of a PLC enzyme.  The structure offers insight 
into the specific regulation of PLC-β2 family members and suggests a previously 
unrecognized role of the XY linker region in regulating catalysis.
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Introduction 
  In response to the initial activation of a vast array of cell surface receptors by 
agonists such as hormones, neurotransmitters, and chemoattractants, phospholipase C 
(PLC) enzymes catalyze the hydrolysis of the minor membrane component, phosphatidyl 
inositol (4,5) bis-phosphate (PtdIns(4,5)P2) into the second messengers diacylglycerol 
(DAG) and inositol (1,4,5) tris-phosphate (Ins(1,4,5)P3).  These second messengers 
stimulate the activity of protein kinase C and trigger the release of intracellular calcium 
stores, respectively.  Signaling cascades initiated by both of these pathways control a 
multitude of cellular functions. 
PLC isozymes constitute a diverse family of signaling molecules divided into six 
families based on sequence conservation (β, δ, γ, ε, ζ and η)4.  All PLC family members 
catalyze a common biochemical reaction and share a conserved core domain architecture 
typified by PLC-δ.  This architecture is comprised of an N-terminal pleckstrin homology 
domain (PH), a series of EF hands, a split catalytic TIM barrel, and a C-terminal C2 
domain.  Initially, the enzymatic hydrolysis of PtdIns(4,5)P2 by PLC isozymes was 
ascribed to two regions of the enzyme originally identified as X and Y.  These two 
regions were later recognized to be the N-terminal half of the TIM barrel and the C-
terminal half plus the C2 domain.  The identifiers X and Y have since been used to 
describe only the two halves of the catalytic TIM barrel.  All PLC isozymes possess this 
split catalytic domain connected by a linker region, which is highly variable in both 
length and sequence.  The function of this linker region remains unclear.  However, in 
both PLC-δ and PLC-β family members, removal of the linker increases the basal 
catalytic activity of the enzyme22,62.  PLC-γ possesses several domains within this linker 
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known to mediate protein-protein interactions required for the stimulation of 
phospholipase activity and RhoA stimulated activity of PLC-ε has been attributed to a 
region of the Y box proximal the C-terminal end of the XY linker57. 
Additional regulatory domains elaborate the conserved core architecture of all 
PLC family members besides PLC-δ to confer specific modes of regulation.  For 
instance, PLC-β family members possess a long C-terminal coiled coil domain connected 
to the C2 domain by a long flexible linker.  This domain mediates homodimerization of 
the enzyme7.  PLC-β also binds Gαq-GTP subunits and facilitates an atypical GTPase 
accelerating activity on Gαq through interactions with this C-terminal domain8.  
However, other regulators of PLC-β isozymes bind to the core architecture of the 
enzyme.  The small Rho family GTPases, Rac1-3, bind directly to the PH domain of 
PLC-β isozymes and stimulate their capacity to hydrolyze PtdIns(4,5)P249.  Gβγ subunits 
of heterotrimeric G proteins also stimulate the enzymatic activity of PLC-β family 
members through direct interactions.  However, the exact nature of these binding events 
remains unclear.  Conflicting accounts delineate different regions of the conserved core 
of PLC-β as being responsible for Gβγ subunit binding.  Both the PH domain and a 
portion of the catalytic TIM barrel have been identified as being required for maximal 
stimulation of PLC-β by Gβγ (Figure 1)36,37.   
Despite extensive biochemical and sequence-based characterization of the domain 
architecture of many PLC family enzymes and identification of various regulatory 
binding partners such as Gβγ, little is known of the three-dimensional domain 
organization or the structural basis for regulation of these enzymes.  Two crystal 
structures of PLC-δ comprise the majority of structural information of the conserved PLC 
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core architecture13,14.  While these structures elucidated the details of the catalytic 
mechanism of PtdIns(4,5)P2 hydrolysis and the regulation of PLC-δ by PtdIns(4,5)P2, 
they offered few insights into the regulation of other PLC family members. 
Here we present the high-resolution crystal structure of the complete conserved 
core of PLC-β2.  Unlike the structures of PLC-δ, the core of PLC-β2 is intact, 
demonstrating extensive interactions between the PH domain and the remainder of the 
enzyme.  The coordinated three-dimensional organization of these domains suggests a 
mode of regulation for PLC-β2 that differs greatly from that of PLC-δ.  However, the 
presence of the XY linker occluding the active site of the enzyme suggests a possible 
regulatory mechanism conserved across all PLC family members.
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Results and Discussion 
Overall structure of the conserved core of PLC-β2 
The crystal structure of a fragment of human PLC-β2 containing the conserved 
core architecture of the enzyme was determined and refined at 1.6 Å using molecular 
replacement (Tables 2.1 and 2.2).  The structure of an identical construct of PLC-β2 
bound to the small GTPase, Rac1 (PDB accession number 2FJU), was used as a search 
model after removal of the GTPase (chapter 3).  Due to the exact sequence identity 
between the structural model used for molecular replacement and the structure being 
determined, molecular replacement was carried out both with and without the PH domain 
present in the search model.  Additionally, model bias was eliminated by calculating a 
simulated annealing composite omit map for the construction of the final model. 
The fragment of PLC-β2 crystallized spans from the N-terminal PH domain to the 
C-terminus of the C2 domain (residues 1-799).  The C-terminal extension containing the 
coiled coil domain responsible for Gαq binding, activation, and atypical GTPase activity 
was eliminated to reduce the inherent flexibility of the construct and to aid in 
crystallization.  Various regions of PLC-β2 are disordered in the crystal structure; 
specifically residues 1-11, 80-92, 223-238, 250-267, 276-286, and 465-516 are absent 
(Figure 2). 
The overall structure of PLC-β2 displays a tightly packed planar geometry 
consistent with the enzyme’s role of binding lipid substrate molecules at membrane 
surfaces (Figure 3).  Comparison of the structure of PLC-β2 with the canonical core 
architecture of PLC-δ1 (PDB accession code 1DJX) reveals that the two enzymes possess 
a high degree of structural similarity in both the catalytic TIM barrel and C2 domains 
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(r.m.s. deviation = 0.98 Å for all elements of secondary structure).  However, differences 
in the positions of the EF hands in the two structures are readily apparent.  In both 
structures, the EF hands are incomplete (Figure 2).  However, the ordered regions in both 
models differ and the positions of shared secondary structure elements vary dramatically.  
Both of these differences can be attributed to the inherent flexibility of the EF hands in 
both PLC-δ1 and PLC-β2.  However, the most striking difference between the two 
phospholipases is the presence of the PH domain in the PLC-β2 structure. 
Pleckstrin homology domain 
Unlike the PH domain of PLC-δ1, the PH domain of PLC-β2 is clearly visible in 
the intact crystal structure.  This domain is sandwiched between both the EF hands and 
the catalytic TIM barrel burying extensive solvent accessible surface areas at both 
interfaces (Figure 3).  The structure of the PH domain of PLC-δ1 required independent 
determination from that of the remainder of the catalytic core due to its inherent mobility 
and the flexibility of the linker connecting it to the EF hands.  However, the PH domain 
of PLC-β2 forms various specific interactions with the remainder of the enzyme.  
Specifically, three ring-containing residues and a methionine (Tyr 46, Phe 48, Met 56, 
and Tyr 58) along β-strands 3 and 4 of the PH domain form a highly hydrophobic 
interface, which packs along the face of EF hand helix 1.  In contrast to the hydrophobic 
interface that the PH domain shares with the first EF hand, the interactions of the PH 
domain with the catalytic TIM barrel are predominantly polar.  A variety of charged 
residues along β-strand 6 of the PH domain (Arg 65, Asp 66, and Arg 68) form a tight 
network of hydrogen bonds and salt bridges with residues Glu 343, Arg 346, Ser 351, Glu 
393, and Lys 397 of helices 1 and 2 of the TIM barrel.  The interface of the PH domain 
37
and the TIM barrel bury approximately 1600 Å2 of otherwise solvent accessible surface 
area.  This extensive set of intermolecular interactions indicates that the PH domain 
remains tightly packed against the core domain architecture at all times and that 
interactions with regulators mediated through the PH domain may require the specific 
orientation of this domain relative to the catalytic core of the enzyme to ensure proper 
activation of phospholipase activity. 
EF hand domain 
The EF hand regions of PLC-β2 share the canonical helix-loop-helix topology of 
various other EF hands including calmodulin and PLC-δ1.  As in the structure of PLC-δ1, 
electron density for the EF hands of PLC-β2 is incomplete preventing the comprehensive 
modeling of the domain.  Specifically, the loops of EF hands 3 and 4 and the interhelical 
linker between the two EF hands are missing from the final structure.  Although the 
absence of these loops suggests an intrinsic flexibility of these regions, it should be noted 
that the helical secondary structural elements of the EF hand motifs are all present 
(Figure 2).  Taken together, the structures of the EF hands of both PLC-δ1 and PLC-β2 
suggest the entire EF regions of both enzymes may be highly mobile in the absence of 
specific packing interactions, but within PLC-β2 they are reinforced by interactions with 
the PH and C2 domains.  The EF hands of PLC-β2 are also located within the plane of 
the enzyme directly adjacent to both the PH domain and the C2 domain whereas the EF 
hands seen in the structure of PLC-δ1 are positioned slightly below the plane of the entire 
molecule (Figure 4).  This again reinforces the conclusion that the EF hands of PLC-β2 
are held in place by specific intermolecular interactions not found in the domain 
architecture of PLC-δ1. 
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Catalytic TIM barrel 
As predicted by the high degree of sequence identity between the two enzymes, 
the catalytic TIM barrel of PLC-β2 is nearly identical to that seen in the crystal structure 
of PLC-δ1.  The two domains share all secondary structural elements outside of the XY 
linker and superimpose with an r.m.s. deviation of 0.7 Å.  The residues of the catalytic 
site required for the hydrolysis of PtdIns(4,5)P2 are identical in both structures 
demonstrating that enzymatic specificity is controlled not by differences in catalysis, but 
instead by various regulatory mechanisms.  The structure of PLC-β2 suggests another 
possible mode of regulation in addition to the packing of the regulatory PH domain, 
known to bind Gβγ subunits and the small GTPase, Rac1, against the catalytic TIM 
barrel.  The XY linker region of the TIM barrel is partially modeled in the structure of 
PLC-β2.  Electron density maps used for model building and structural refinement 
included significant density for the C-terminal end of the XY linker.  Specifically, 
residues 516-540 of the XY linker were modeled as a helical extension linked by an 
unstructured loop to the fourth α-helix of the TIM barrel (Figure 5).  Despite the absence 
of N-terminal residues of the XY linker (465-515) in the crystal structure, the portion of 
this region that was modeled offers intriguing insights into the regulation of PLC-β2 
mediated catalysis.  The C-terminal end of the helix and a segment of the loop found in 
the XY linker partially occlude the substrate-binding site of the catalytic domain.  
Residues involved in the binding and hydrolysis of PtdIns(4,5)P2 at the catalytic site 
bound to residues within the modeled segment of the XY linker (Figure 6).  Hydrogen 
bonds between both His 374 and Glu 408 of the catalytic site with Thr 531 of the XY 
linker provided critical support for the occlusion of the substrate-binding site.  In addition 
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to these specific contacts, the backbone of the XY linker occupies the same position of 
PtdIns(4,5)P2 docked into the substrate-binding pocket (Figure 5).  This result is 
consistent with failed attempts to co-crystallize PLC-β2 with the enzymatic product, 
Ins(1,4,5)P3.  While the XY linker of all PLC enzymes is highly variable, previous 
biochemical data in conjunction with the structural details of the linker of PLC-β2 
suggest that regulation of all PLC activity may be mediated at least in part by interactions 
with the intervening sequence of the catalytic X and Y regions.  The steric occlusion of 
the substrate-binding pocket of PLC-β2 by the XY linker suggests that the basal activity 
of the enzyme is inhibited by its inability to bind substrate.  This hypothesis derived from 
the structure is supported by biochemical experiments confirming such a basal inhibition 
(data not shown).  In cotransfection assays where PLC-β2 is expressed in COS-7 cells 
along with Gβγ, both stimulated and basal phospholipase activities are increased when 
the linker is deleted.  However, through interactions with the phospholipid membrane 
and/or protein regulators, this inhibitory binding may be eliminated to facilitate catalysis.  
One leading candidate for such regulation is the Gβγ subunit of heterotrimeric G proteins.  
Although some studies have delineated the PH domain of PLC-β as the primary binding 
site for Gβγ subunits36, others have indicated that a portion of the catalytic domain 
mediates at least some of the interactions with Gβγ64.  Gβγ subunits are believed to 
stimulate the capacity of PLC-β isozymes to hydrolyze PtdIns(4,5)P2 by directly binding 
to the enzyme and localizing it to a substrate containing membrane.  However, the 
structural data presented here offer a tantalizing suggestion that an additional mechanism 
exists whereby basal inhibition is relieved upon Gβγ binding to the XY linker of PLC-β.  
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At this point, further biochemical and structural studies are required to confirm this 
hypothesis. 
One additional observation concerning the catalytic TIM barrel of PLC-β2 was 
the presence of a calcium ion in the catalytic site.  Calcium was not present in any of the 
buffers used to purify or crystallize PLC-β2, therefore the presence of the ion in the 
crystal structure indicates that it was bound with high affinity in intact cells prior to 
purification.  This ion in the catalytic site is the only cacium ion found in the structure 
and is therefore consistent with the known role of calcium in regulating all PLC enzymes.   
 
C2 domain 
 Similar to that of PLC-δ1, the structure of PLC-β2 positions the C2 domain 
between the EF hands and TIM barrel of the enzyme.  As predicted by sequence 
similarity, the C2 domain shares near perfect structural identity with that of PLC-δ1.  Its 
identical orientation relative to the TIM barrel indicates that the tight packing of the two 
domains is invariant across the PLC family.  However, the functions of the C2 domains 
of PLC-δ1 and PLC-β2 differ.  Numerous structures of the C2 domain of PLC-δ1 have 
been determined and the mechanism of activation mediated by this domain has been 
extensively characterized13,23,24.  The loops of the C2 domain of PLC-δ1 termed “jaws”, 
which are modeled to face a substrate-containing membrane, bind calcium ions through a 
series of acidic residues.  This binding event forms a cation-mediated interaction with 
acidic lipids and insures the anchoring of the enzyme to the plasma membrane.  However, 
the jaws of the C2 domain of PLC-β2 differ from those of PLC-δ1 in that they lack the 
acidic residues required for calcium binding.  However, the structural conservation of the 
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C2 domain and its orientation towards the planar membrane-binding face of PLC-β2 
suggest the domain may still be required for proper membrane localization.  Whether 
binding to specific lipid head groups, nonspecific membrane binding, or protein/protein 
interactions mediate the interaction between the C2 domain of PLC-β2 and the plasma 
membrane remains unknown. 
 The high-resolution crystal structure of PLC-β2 presented here provides the first 
structural information of the entire intact conserved core architecture of PLC enzymes.  It 
provides insights into previously documented mechanisms for the regulation of PLC-β2 
activity and also suggests the existence of further regulatory mechanisms.  The exact 
nature of such regulatory mechanisms remains to be identified.  However, the structure 
presented here and ongoing work in our laboratory indicate that the XY linker of PLC-β2 
plays a primary role in modifying the intrinsic and stimulated enzymatic activity of the 
enzyme.  Whether regulation of all PLC family members is mediated through interactions 
with this linker requires further structural and biochemical investigation.  Identification of 
the role of the XY linker in the regulation of PLCs δ, γ, and ε are ongoing and will 
greatly expand our understanding of the intricate coordination of PLC signaling.  
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Methods 
Expression and purification 
 A fragment of human phospholipase C β2 spanning from the N-terminus of the 
PH domain to the C-terminus of the C2 domain (residues 1-799, PH-C2) was subcloned 
into the baculovirus vector, pFastBacHTa and modified by the addition of an N-terminal 
poly-histidine affinity tag followed by a tobacco etch virus (TEV) protease site.  
Baculovirus containing this construct was amplified and expressed in Hi-5 insect cells.  
After 48 hrs of infection at 27 °C, cells were centrifuged and pellets were collected and 
lysed.  The soluble fraction of the cell lysate was initially applied to an immobilized Ni+2 
ion affinity chromatography column and eluted in buffer containing 40% imidazole.  
Fractions containing the desired overexpressed construct were pooled and cleaved with 
TEV to remove the poly-histidine affinity tag.  PLC-β2 PH-C2 was further purified by 
cation exchange and size exclusion chromatography.  Final protein fractions were 
concentrated to 15 mg/ml in storage buffer containing 300 mM NaCl, 20 mM Tris (pH 
7.5), 2 mM DTT and 5% glycerol.   
Crystallization, structure determination, and refinement 
Crystals were grown in sitting drops by vapor diffusion of a 1:1 (v/v) protein 
solution to well solution (16% isopropanol, 2% dioxane, 5% glycerol, 100 mM Tris (pH 
= 8.5)) at 18°C.  Crystals of the spacegroup P212121 with cell dimensions of a = 80.4 Å, b 
= 85.76 Å, and c = 145.4 Å and α = β = γ = 90º grew to diffraction quality within one 
week.  Crystals were cryoprotected by stepwise equilibration into a storage buffer 
containing well solution supplemented with 25% glycerol and were then flash cooled and 
stored in liquid nitrogen. 
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Native data were collected on SER-CAT beamline 22-ID at the Advanced Photon 
Source at Argonne National Labs  (λ = 1.07 Å).  All data were indexed and processed 
using HKL2000.  The program PHASER65 was used to locate a molecular replacement 
solution using a search model obtained from the structure of activated Rac1 bound to 
PLC-β2 PHC2 (PDB accession number 2FJU).  To eliminate model bias in the region of 
the PH domain known to bind the small GTPase, Rac1, the molecular replacement search 
was also conducted with the same model lacking the PH domain.  The model was built 
and refined using the programs O66 and CNS67 with bulk solvent correction, respectively. 
Data collection and structure refinement statistics are shown in Tables 2.1 and 2.2.  All 
molecular model figures were created using the program PyMol. 
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Table 2.1. 
Data collection statistics 
Space group P212121 
Cell dimensions     (Å) 
                               (°) 
a = 80.40 b = 85.76, c = 145.40 
α = β = γ = 90 
Wavelength (Å) 1.07 
Resolution   (Å) 50 – 1.6 (1.7 – 1.6)* 
Rsyma 0.073 (0.241) 
Ι / σ b 21.5 (6.8) 
Completeness (%) 99.9 (96.2) 
Redundancy 6.7 
*Values in parentheses refer to the highest resolution shell 
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Table 2.2. 
Refinement statistics 
Resolution (Å) 20.0 – 1.6 
No. reflections 135439 
     Working set 126769 
     Test set 6779 
Rworkc / Rfreed (%) 20.2 / 22.1 
No. atoms  
     Protein 5556 
     Ligand/ion 1 
     Water 1306 
Wilson B-factor (Å2)  
 Protein 18.00 
 Ligand/ion  6.69 
 Water 32.58 
R.m.s deviations  
 Bond lengths (Å)  .0005 
 Bond angles (°) 1.3 
Ramachandran Plot (%)  
     Most favoured 89.1 
     Allowed 10.9 
     Disallowed 0.0 
aRsym = 100 x Σ|1-<Ι>/Σ|, where I is the integrated intensity of each reflection. 
bΙ / σ = mean signal to noise, where I is the integrated intensity of a measured reflection, and σ is 
the estimated error in measurement. 
cRwork = Σ |Fo - Fc| / ΣFo, where Fo and Fc are the observed and calculated structure factor 
amplitudes. 
dRfree is calculated as defined by Rwork using test set reflections (5% of the total). 
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Figure 1
PLC-β
Multiple inputs impinge on PLC-β function.
The heterotrimeric G-proteins Gαq and Gβγ have previously been shown to bind to and
stimulate the catalytic activity of PLC-β iszoymes.  Recently, the small GTPase Rac has
also been described as a modulator of PLC-β activity.  The domains of PLC-β known to
mediate these interactions are indicated by arrows.  The convergence of these disparate
signaling inputs results in the intricate regulation of PLC activity downstream of a
multitude of cell surface receptors.  
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 Figure 2 Sequence and structural alignments of PLCδ1 and PLCβ2 
 
Sequence and structural alignments of PLCδ1 and PLCβ2 based on the crystal 
structures of PLCδ1 (PH domain and EF-C2 domains) and the structure of 
PLCβ2 (PH-C2) alone show a high degree of structural similarity.  Grey dashed 
lines indicate regions of both proteins absent in the crystal structures.  Asterisks 
indicate residues required for phospholipid binding.   
49
Figure 3
TIM
PH
EF
C2
Overall structure of the conserved core of PLC-β2.
The four domains that form the core architecture of PLC-β2 pack together to form
a tight module.  The PH domain shares extensive surface area with both the catalytic
domain and the EF hands indicating that it is permanently docked between the two
other domains and not attached by a flexible linker as is the case of the PH domain
of PLC-δ.    
50
Figure 4
TIMEF C2
TIM
EF
C2
PLCδ
PLCβ2
Superposition of the structure of PLC-β2 with PLC-δ1
The catalytic TIM barrel and C2 domains of PLC-β2 are nearly identical in structure
to those of PLC-δ1.   The EF hands of PLC-β2 diverge significantly from the
positions of those in PLC-δ1.  The PH domain of PLC-β2 was omitted from this
model to facilitate comparison with the structure of PLC-δ1, which lacks its PH
domain.  
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Figure 5 XY linker
TIM Ins (1,4,5)P3
The XY linker region of PLC-β2 occludes the substrate-binding pocket.
A surface representation of the catalytic TIM barrel of PLC-β2 indicates that the XY linker 
region, which joins the two halves of the TIM barrel, also binds the catalytic site of the 
enzyme, thereby preventing substrate access.  Ins(1,4,5)P3 was docked according to the
coordinates given in the structure of PLC-δ. 
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Figure 6
The XY linker blocks PtdIns(4,5)P2 binding.
The linker of the catalytic TIM barrel occupies the same space as the
site for PtdIns(4,5)P2 binding providing a possible mechanism for
regulation of phospholipase activity.  Intramolecular hydrogen bonds
betwen histidine and glutamic acid residues and the side chain of Thr
351 stabilize the conformation of the linker. 
Thr 531
Glu 408
His374
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Abstract 
Extracellular stimuli as diverse as chemoattractants, hormones, and 
neurotransmitters all initiate signal transduction pathways comprised of 
heterotrimeric G proteins and downstream effectors such as phospholipase C.  
Small GTPases of the Ras superfamily also function as ubiquitous signaling proteins 
that regulate cellular events such as cell division, proliferation, and chemotaxis.  
Although diverse signaling cascades require the coordinated regulation of 
heterotrimeric G proteins and small GTPases related to Ras, connections between 
these two families of signaling proteins remain poorly understood.  Here we present 
the crystal structure of the small GTPase, Rac1, bound to phospholipase C-β2, a 
classic effector of heterotrimeric G proteins (Gαq and Gβγ).  Activated Rac1 
engages solely the pleckstrin homology domain of PLC-β2 to optimize its affinity 
and orientation for substrate membranes.  Gβγ must also engage the pleckstrin 
homology domain to activate PLC-β2 and these two activation events are mutually 
compatible leading to additive stimulation of phospholipase activity.  In contrast to 
the intensively studied PLC-δ isozymes, the pleckstrin homology domain of PLC-β2 
cannot bind phosphoinositides and this common mode of regulation is definitively 
eliminated.  Finally, the structure also reveals the determinants that dictate the high 
selectivity of PLC-β isozymes for Rac GTPases versus other Rho-family GTPases 
and specific substitutions within PLC-β2 abrogate its stimulation by Rac1 but not 
Gβγ, allowing for the dissection of this integral signaling node. 
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Introduction 
Phospholipase C enzymes catalyze the hydrolysis of phosphatidyl inositol (4,5) 
bis-phosphate into the second messengers diacylglycerol and inositol (1,4,5) tris-
phosphate.  These second messengers regulate the activity of PKC and the release of 
intracellular calcium stores, respectively: thereby initiating essential signaling cascades 
responsible for the regulation of myriad cellular responses.  There are thirteen PLC 
isozymes in humans that are grouped by sequence conservation into six families (β, δ, γ, 
ε, ζ and η).  In general, these PLC families share a conserved core architecture consisting 
of an N-terminal pleckstrin homology (PH) domain followed by a series of EF-hands, a 
catalytic TIM barrel, and a C-terminal C2 domain (Figure 1).  This core architecture is 
further elaborated in the various families to provide unique modes of regulation.  For 
instance, PLC-β isozymes possess an all-helical, C-terminal domain necessary for 
homodimerization and stimulation of phospholipase activity through direct interactions 
with Gα-GTP subunits of the Gq-family26-28,68,69.  Gβγ subunits also directly activate 
PLC-β isozymes33,34,70,71. Although the characterization of these pathways has been 
extensive, the complexity of PLCβ regulation was greatly expanded with the discovery 
that guanine nucleotide binding proteins of the Rho family of GTPases also directly 
activated PLCβ isozymes.  Specifically, the small GTPases, Rac1-3, directly activate 
PLC-β2 and -β349.  Thus PLC-β isozymes serve as an important node to coordinate 
signals propagated by various heterotrimeric G proteins and Rac GTPases.  Here we 
present the high-resolution crystal structure of the conserved core of PLC-β2 in complex 
with activated Rac1.  This structure and the supporting biochemistry provide important 
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details for understanding the basal activity of PLC-β isozymes and their stimulation by 
Rac GTPases and heterotrimeric G proteins. 
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Results and discussion 
Overall crystal structure 
The crystal structure was determined using a combination of multiwavelength 
anomalous dispersion and molecular replacement (Tables 3.1 and 3.2).  The refined 
structure, at 2.2 Å resolution, consists of the core of PLC-β2 (residues 1 – 799) in 
complex with activated Rac1 (residues 1 – 189) bound to the non-hydrolyzable 
nucleotide analog, GTPγS.  Several regions of PLC-β2 are disordered (residues 1-12; 
220-265; 274-286 and 465-534); in addition, the C-terminal homodimerization domain 
(800 – 1181) was deleted to facilitate crystallization.  To eliminate model bias caused by 
molecular replacement, a simulated annealing composite omit map was calculated 
(Figure 2).  The overall structure of the complex displays a planar triangular geometry 
with the three vertices formed by Rac1, the TIM barrel, and the EF hands of PLC-β2 
(Figure 3).  The relative positions of backbone atoms in the TIM barrel and the C2 
domain are superimposable with those seen in the structure of the catalytic core of PLC-
δ, possessing r.m.s. deviations of 0.78 Å and 1.05 Å, respectively (Figure 4).  Within the 
complex, the switch regions of Rac1 are used almost exclusively to engage the PH 
domain of PLC-β2 (Figures 3 and 5).  Only the PH domain of PLC-β2 is involved in 
complex formation.  This arrangement is consistent with previous biochemical and cell 
biological studies that indicated that the PH domains of PLC-β2 and -3 were the major 
binding determinants for Rho-family GTPases18,48,49.  Furthermore, this arrangement is 
consistent with the GTP-dependence of Rac1 binding to PLC-β isozymes and its 
subsequent phospholipase activation.  The state of the bound guanine nucleotide 
determines the conformation of the switch regions of GTPases.  In the GTP-bound form, 
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these switch regions engage effectors in order to couple GTPase activation to the 
initiation of downstream signals.  Therefore, the structure supports and greatly extends 
our understanding of PLC-β2 as a genuine effector of Rac GTPases. 
The structure also highlights striking difference in the regulation of PLC-β 
isozymes versus the well-studied PLC-δ isozymes.  For instance, extensive biochemical 
and structural data indicate that the PH domains of PLC-δ isozymes preferentially bind 
PtdIns(4,5)P2 to anchor these phospholipases to lipid bilayers for efficient, processive 
hydrolysis of phosphoinositides in a process termed “membrane scooting”14,17.  Data have 
conflicted on whether PLC-β isozymes use such a mechanism.  However, inspection of 
the sequence and structure of PLC-β2 (Fig 6) indicate that PLC-β isozymes lack the 
necessary residues and electrostatic potentials required to bind phosphoinositides through 
their PH domains, effectively eliminating “membrane scooting” as a regulatory 
mechanism (Figure 7a).  Instead, the Rac GTPases, which are membrane-associated, 
serve this function for PLC-β2 and most likely PLC-β3 (Figure 7b).  It is also possible 
that other proteins engage PLC-β isozymes through their PH domains to anchor these 
PLCs for enhanced phospholipase efficiency.  Certainly, Gβγ, which is membrane-
associated and known to interact directly with the PH domains of PLC-β isozymes, is a 
likely candidate for such a regulatory mechanism. 
The PH domain of PLC-β2 also interacts extensively with its catalytic TIM barrel.  
The surface of the PH domain of PLC-β2 that binds the TIM barrel is formed by β-strand 
5, the loop between β-strands 6 and 7, and the C-terminal helix of the PH domain.  These 
regions pack against helices 1, 2, and 7 of the TIM barrel, burying approximately 1600 
Å2 of solvent accessible surface area.  In contrast, a flexible linker tethers PH domains of 
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PLC-δ isozymes to their catalytic cores.  The contrast of these two domain linkages 
suggests that the binding of Rac1 to the PH domain of PLC-β2 not only localizes PLC-β2 
at membranes, but also optimizes the orientation of PLC-β2 at membrane interfaces to 
promote favorable access of the catalytic TIM barrel to phosphoinositide substrates.  The 
likely membrane orientation of the complex of Rac1 and PLC-β2 justifies this 
assumption (Figures 5 and 7).  Superposition of the independently determined structure 
of an identical fragment of PLC-β2 without bound Rac indicates that complex formation 
does not propagate significant allosteric changes within PLC-β2 (0.9 Å r.m.s.d. for 
residues 322 – 799 of PLC-β2) that might otherwise enhance phospholipase efficiency 
(Figure 8).  It must be noted however, that the active sites within both free PLC-β2 and 
PLC-β2 bound to Rac1 are occluded by identical portions of a large loop within the TIM 
barrel that is commonly referred to as the X/Y linker.  This common steric occlusion 
inhibits the phospholipase activity of PLC-β2 (data not shown) and the mechanism of 
release of this inhibition remains unclear.   
Rac1/PH domain interface 
The switch regions of Rac1 clamp down on a hydrophobic ridge spanning the 
surface of the PH domain (Figure 9) to bury approximately 1200 Å2 of surface area.  
Specifically, Val 36 and Phe 37 of switch I along with Tyr 64 and Trp 56 of switch II 
interdigitate with Arg 22, Gln 52, and Tyr 118 of the PH domain of PLC-β2.  
Furthermore, the α-helix of switch II buries Leu 67 and Leu 70 into a shallow 
hydrophobic groove formed by Ile 24, Pro 35, Val 84, and Tyr 118 of the PH domain.  
An extensive series of hydrogen bonds and electrostatic interactions provides further 
support and specificity for the interface (Figure 10).  For example, Phe 37 and Tyr 64 of 
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Rac1 bracket Tyr 118 of PLC-β2 to form a series of off-angle, edge-to-face, π-orbital 
stacking interactions.  Also, Gln 52 of PLC-β2 is central to the interface where it is 
responsible for supporting the position of five distinct residues of Rac1 encompassing 
both switches:  it is sandwiched between Phe 37 and Trp 56; forms hydrogen bonds with 
the side chains of Asn 39 and Ser 71; and participates in a water-mediated hydrogen 
bonding network with the backbone carbonyl oxygen of Asp 57.  Arg 22 of PLC-β2 also 
supports the burial of Gln 52 by buttressing Phe 37 of Rac1 while hydrogen bonding with 
the side chain of Asp 38.  These highly specific interactions allow Rac1 to bind the PH 
domain of PLC-β2 efficiently while burying a limited amount of solvent accessible 
surface area.   
GTPase/PLC-β  effector specificity 
The residues in Rac1 that engage PLC-β2 share almost perfect identity with those 
in the prototypical Rho-family GTPases Cdc42 and RhoA (Figure 11a).  Nonetheless, 
only the Rac isozymes bind significantly to PLC-β2 and -β3 leading to their activation.  
Calculations of the electrostatic surface potentials of these GTPases (Figure 12) indicate 
that Rac1 and Cdc42 have roughly similar electrostatic potentials while RhoA is highly 
electronegative.  Given that the PH domain of PLC-β2 also possesses a highly negative 
lobe of electrostatic potential, significant electrostatic repulsion should disfavor complex 
formation between RhoA and PLC-β2, irrespective of potential specific intermolecular 
interactions.  Similar differences in electrostatics have been suggested to determine the 
specificity of other GTPase / effector pairs72.  For Cdc42, the equivalent of the critical 
interfacial Trp 56 of Rac1 is replaced with Phe 56.  This smaller residue most likely 
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reduces the stability of the interface by creating defective packing and reduced burial of 
hydrophobic surface.   
Conversely, the significant preference of Rac1 for PLC-β2 relative to PLC-β3 as 
well as the inability of Rac1 to activate PLC-β1 is attributable to sequence differences 
within the phospholipases (Figure 11b).  For example, critical interfacial residues at 
positions 22 and 52 are substituted in PLC-β1 and -β3.  Furthermore, the equivalent of 
Val 84 of PLC-β2 is substituted with a bulkier leucine in PLC-β1, which is expected to 
partially fill the hydrophobic groove within the PH domain needed to engage switch 2 of 
Rac1.  This residue is not substituted in PLC-β3 and might explain the capacity of Rac to 
activate PLC-β3 only modestly.   
Identification of residues critical for complex formation 
To identify functionally important residues within the interface, a series of single 
substitutions within both Rac1 and PLC-β2 were tested for their effects on the capacity of 
constitutively active Rac1(G12V) to stimulate PLC-β2 in COS-7 cells (Figure 13a).  
Substitution with alanine at several positions within the switch regions of Rac1, i.e., Phe 
37, Trp 56, Leu 67 and Leu 70, significantly reduced stimulation of PLC-β2.  Consistent 
with the need for GTPases to couple alterations in the conformation of the switch regions 
with the binding and activation of downstream effectors, several of these sites have been 
implicated previously as necessary for effector modulation by Rho-family GTPases73.  
For PLC-β2, substitution of Gln 52 with alanine greatly diminishes phospholipase 
stimulation by Rac1, reaffirming the central role of this residue in supporting the 
interface with Rac1 (Figure 13b).  Importantly, Q52A does not significantly affect 
stimulation of PLC-β2 by Gβ1γ2, indicating that the binding sites for Rac1 and Gβ1γ2 
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within the PH domain of PLC-β2 are distinct and supporting the capacity of both Rac and 
Gβγ to stimulate PLC-β2 simultaneously.   
The work presented here demonstrates the mechanism by which Rac1 achieves 
specific binding and activation of its effector, PLCβ2.  It represents the first structural 
evidence to support the rapidly developing theme that small GTPase/phospholipase 
complexes comprise a major class of protein/effector interactions essential for crosstalk 
between small GTPase and heterotrimeric G protein signaling pathways.  Early 
biochemical studies have identified additional interactions between the small GTPases 
Ras and Rac and PLC-γ isozymes and Ras, RhoA, and Rap with PLC-ε.  Structural and 
biochemical characterization of these interactions will identify and elucidate common 
motifs and greatly expand the understanding of these essential signaling nodes.  Further 
identification of such interactions, their subsequent characterization, and the dissection of 
their cellular functions will also provide a detailed understanding of the pivotal role these 
molecules play in controlling a vast array of physiological processes. 
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 Methods 
Expression and purification 
To minimize sample heterogeneity and facilitate bacterial expression of Rac1, the 
C-terminal site of post-translational modification was eliminated by truncation of three 
C-terminal residues and mutating Cys189 to serine.  Expression and purification of Rac1 
(residues 1-189, C189S) were performed as previously described74.  A fragment of 
human phospholipase C β2 spanning from the N-terminus of the PH domain to the C-
terminus of the C2 domain (residues 1-799, PH-C2) was subcloned into the baculovirus 
expressing vector, pFastBacHTa, expressed in Hi-5 insect cells, and purified as 
previously described48. 
Crystallization, structure determination, and refinement 
Prior to crystallization, purified Rac1 was loaded with the non-hydrolyzable GTP 
analogue, GTPγS.  Activated Rac1-GTPγS was combined with PLC-β2 (PH-C2) in a 1:1 
molar ratio, buffer exchanged into storage buffer (300 mM NaCl, 50 mM Tris (pH 7.5), 
and 2 mM DTT), and concentrated to 15 mg/ml.  Crystals were obtained in sitting drop 
by vapor diffusion of a 1:1 (v/v) protein solution to well solution (8% w/v PEG 3350 and 
50 mM Tris (pH 8.5)) at 4°C.  Crystals of the spacegroup P3221 (a = b = 185.8 Å, c = 
93.8 Å, α = β = 90°, γ = 120°) formed within 48 hrs and contained one Rac1-GTPγS / 
PLC-β2 (PH-C2) complex in the asymmetric unit with a solvent content of approximately 
75%.  Platinum derivatized crystals were obtained by soaking native crystals in 
crystallization buffer supplemented with 10 µM K2PtCl4 for 24 hrs at 18°C.  
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Cryoprotection and back-soaking were achieved by stepwise equilibration in 
crystallization buffer containing 30% (v/v) glycerol.  Native and MAD datasets were 
collected on SER-CAT beamline 22-ID at the Advanced Photon Source at Argonne 
National Labs  (λ1 = 11,560 eV, λ2 = 11,563.6 eV, λ3 = 11,660).  All data were indexed 
and processed using HKL2000.  The CCP475 program AMORE was used to locate two 
partial molecular replacement solutions using search models obtained from the structures 
of activated Rac1 (PDB accession number 1MH1) and the catalytic domain of PLC-δ 
(PDB accession number 1DJX).  The locations of five platinum sites were determined 
using the program SHELXS76 and refined through MLPHARE using structure factors 
obtained from the two molecular replacement solutions.  Solvent flattening was 
performed using the program DM.  The model was built and refined using the programs 
O66 and CNS67 with bulk solvent correction, respectively. Data collection and structure 
refinement statistics are shown in Tables 3.1 and 3.2.  All structure figures were created 
using the program PyMol.  Electrostatics calculations were performed for figure 13 using 
the program SPOCK77.   
Inositol phosphate accumulation assays 
Transfection of COS-7 cells was performed as previously described.  Twenty four 
hours after transfection, media were removed and replaced with myo-[3H]inositol 
(1µCi/well) in inositol-free DMEM. After 12 hours, [3H]inositol phosphate accumulation 
was quantified by addition of LiCl to a final concentration of 10 mM. The reaction was 
stopped after 1 hour by aspiration of the medium and cell lysis was achieved by the 
addition of 50 mM formic acid. PLCβ2 activity was measured by the quantification of 
[3H]Inositol phosphates using a scintillation proximity assays as described78.
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Table 3.1.  Data Collection and Phasing Statistics 
Data collection  
Space group P3221 
Cell dimensions     (Å) 
                               (°) 
a = b = 185.82, c = 93.82 
α = β = 90, γ = 120 
Data set Native K2Pt(Cl)4  
peak 
K2Pt(Cl)4  
edge 
Wavelength (Å) 1.000 1.072 1.073 
Resolution   (Å) 50 – 2.2 (2.28 – 2.2)* 30 - 2.8 (2.8 – 2.7) 30 – 3.2 (3.3 – 3.2) 
Rsyma 0.114 (0.348) 0.099 (0.408) 0.172 (0.512) 
I / σ b 18.6 (2.72) 16.2 (2.53) 8.19 (1.51) 
Completeness (%) 99.9 (92.2) 99.4 (94.1) 99.7 (98.1) 
Redundancy 5.8 6.9 5.2 
*Values in parentheses refer to the highest resolution shell 
Phasing    
Sites 5   
RCullisc (centric/acentric) 0.75/0.78   
Phasing powerd (centric/acentric) 1.46/1.06   
Mean figure of merit 0.5050   
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Table 3.2.                   Refinement statistics 
Resolution (Å) 15.0 – 2.2 
No. reflections 93711 
     Working set 89026 
     Test set 4685 
Rworke / Rfreef (%) 20.84 / 22.61 
No. atoms       Protein 7000 
       Ligand/ion 32 
       Water 485 
B-factor (Å2)  Protein 32.573 
  Ligand/ion 28.446 
  Water 32.456 
R.m.s deviations  
 Bond lengths (Å)  .0006 
 Bond angles (°) 1.4 
Ramachandran Plot (%)  
     Most favored 89.9 
     Allowed 10.1 
     Disallowed 0.0 
aRsym = 100 x Σ|1-<I>/Σ|, where I is the integrated intensity of each reflection. 
bI / σ = mean signal to noise, where I is the integrated intensity of a measured reflection, and s is 
the estimated error in measurement. 
cRCullis = Σ|(|Fph| ± |Fp|) - |Fh|| / Σ||Fph| - |Fp|| where Fp and Fph are the observed native and 
derivative structure factors and Fh is the calculated heavy-atom structure factor. 
dPhasing Power = Fh / E where Fh is the calculated heavy-atom structure factor and E is the 
phase-integrated lack of closure. 
eRwork = Σ|Fo - Fc| / Σ Fo, where Fo and Fc are the observed and calculated structure factor 
amplitudes. 
fRfree is calculated as defined by Rwork using test set reflections (5% of the total). 
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PH EF TIM C2 CT
Figure 1
PH EF TIM C2
PH EF TIM C2 RARasGEFCR RA
PLC-δ
PLC-β
PLC-γ
PLC-ε
PH EF
SH2 SH2 SH3
C2HP
Elaboration of core domain architecture of PLC family members.
PLC-β2 possesses the conserved core of all PLC enzymes that includes an N-terminal
pleckstrin homology domain, followed by four EF hands, a catalytic TIM barrel, and a
C-terminal C2 domain.  A C-terminal coiled-coil domain elaborates this core and
mediates homodimerization and phospholipase stimulation by Gαq
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Figure 2
Electron density and fit of Rac bound to PLC-β2.
Residues corresponding to the C terminal helix of the PH domain of PLC-β2 are shown
fit to a composite omit map of electron density contoured at 1.3 σ.  Data were
collected on native and platinum derivatized crystals.  Phases from two partial
molecular replacement solutions (Rac1 and the catalytic domain of PLCδ),  as well
as anomalous and isomorphous data were combined to obtain initial electron
density maps.  The final model was refined to 2.2 Å resolution with an Rwork of 20.8%
and an Rfree of 22.6%.
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Rac
PH TIM
C2EF
N
C
Sw1
Sw2
Figure 3
The overall structure of Rac1 bound to its effector, PLC-β2.
Ribbon diagram of the overall strucutre of Rac1 (green, switch regions in red)
bound to the conserved core of PLC-β2 as viewd from below the plane of the
membrane.  Activated Rac1, bound to the non-hydrolyzable GTP analogue,
GTPγS (cyan), engages solely the PH  domain (blue) of PLC-β2.  Interdomain
linkers are shown in grey.
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Figure 4
TIMEF C2
TIM
EF
C2
PLCδ
PLC-β2
Superposition of the structure of PLC-β2 bound to Rac1 with PLC-δ1
The catalytic TIM barrel and C2 domains of PLC-β2 are nearly identical in structure
to those of PLC-δ1.   The EF hands of PLC-β2 diverge significantly from the
positions of those in PLC-δ1.  The PH domain of PLC-β2 was omitted from this
model to facilitate comparison with the structure of PLC-δ1, which lacks its PH
domain.  
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Sw1
Sw2
geranylgeranyl PI(4,5)P2
plasma membrane
N
Figure 5
Membrane anchored orientation of the Rac1/PLC-β2 complex.  
Rotation about the x-axis by 90° relative to figure 3, demonstrating the
membrane anchored orientation of the Rac1/PLC-β2 complex.  The
geranylgeranylated C-terminus of Rac and the substrate of PLC-β2,
PtdIns(4,5)P2, are modeled as sites of membrane attachment.
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Figure 6 Sequence and structural alignments of PLCδ1 and PLCβ2 
bound to Rac1 
 
Sequence and structural alignments of PLCδ1 and PLCβ2 based on the crystal 
structures of PLCδ1 (PH domain and EF-C2 domains) and the structure of 
PLCβ2 (PH-C2) bound to the small GTPase, Rac1, show a high degree of 
structural similarity.  Grey dashed lines indicate regions of both proteins absent in 
the crystal structures.  Asterisks indicate residues required for phospholipid 
binding.   
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Figure 7
PtdIns(4,5)P2
a PLCδ1
TIM
PH
EF/TIM/C2PH
DAG
Ins(1,4,5)P3
b
Sw1
Sw2
geranylgeranyl
N
PLCβ2
Rac TIM
PH
EF/TIM/C2
PH
PH
DAG
Ins(1,4,5)P3
Rac
PtdIns(4,5)P2
Interactions with PH domains of PLC isozymes dictate their regulation.  
a.  The PH domain of PLC-δ binds to PtdIns(4,5)P2, thereby recruiting PLC-δ to pools of
PtdIns(4,5)P2 for subsequent processive hydrolysis.  
b.  Upon activation, membrane bound isoprenylated Rac1 recruits PLC-β2 to the
plasma membrane by binding the PH domain of the enzyme.  
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Figure 8
EF
C2
PH
TIM
Rac1 binding to PLC-β2 induces no conformational changes.
Superposition of the structures of PLC-β2 bound to Rac (blue) and in
isolation (red) shows near perfect structural identity.  The comparison
of these two structures indicates that Rac1 binding to PLC-β2 does not
stimulate the activity of PLC-β2 by an allosteric mechanism.  
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Figure 9
Sw2Sw1
W56
V36
F37
Y64
Q52
R22
Y118
PH domain
Intermolecular interface of Rac1 and PLC-β2.   
 
Surface representation and schematic of the PH domain of PLC-β2 (grey) 
engaging the switch regions of Rac1 (red).  Contact residues of the PH domain 
are highlighted (blue).   
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R22
Y118
W56
Q52
N39
D38
Y64
F37
S71
V36
Figure 10
Intermolecular interactions between Rac1 and PLC-β2.
Close-up view of Figure 9 highlighting intermolecular contacts.  Gln 52 annd Tyr118
of PLC-β2 form central points of the interface and are stabilized by a tight network of
hydrogen bonds and pi-orbital interactions.  
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Figure 11 Sequence alignments of prototypical GTPases and PLCβ  
isozymes. 
 
a. Alignment of the three prototypical members of the Rho family of small 
GTPases reveals few differences in the position of residues required for complex 
formation with PLCβ2 (yellow).   
b. Alignment of PLCβ isozymes reveals a lack of conservation at residues 
required for complex formation with Rac1 (yellow), specifically positions 22, 52, 
and 94.  
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Rac
RhoA
PLCβ2 PH
Cdc42
interface
Figure 12
Electrostatic interactions restrict the specificity of GTPases for PLC-β2.   
 
All GTPase backbone positions are shown superimposed with electrostatic 
potentials calculated at +/- 2kT and depicted as blue and red contours, 
respectively.  The electrostatic potentials of Rac and the PH domain of PLC-β2 
are highly complementary.  In contrast, RhoA is highly electro-negative and is 
expected to repel the similarly charged PH domain of PLC-β2 
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Figure 13
Mutagenesis of key interface residues reduces Rac stimulated PLC-β2 
activity.   
 
a.  Constitutively active Rac1 (G12V) and mutant forms were co-expressed with 
wild type PLC-β2 in COS-7 cells prior to quantitation of PLC activity as measured 
by the accumulation of inositol phosphates.  Gαq served as a control of 
stimulated phospholipase activity by a classic modulator of PLC-βs.  Relative 
expression of endogenous Rac (vector) and mutant forms is indicated by western 
blot.   
 
b.  Constitutively active Rac1 or Gβ1γ2 were co-transfected in COS-7 cells with 
wild type and mutant PLC-β2 constructs followed by quantitation of PLC activity.  
Relative expression of endogenous PLC-β2 (vector) as well as transfected 
constructs is indicated by western blot. 
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Future directions 
 The complexity of the rapidly burgeoning field of phospholipase C signaling has 
increased with the recent characterization of various small GTPases of the Ras and Rho 
families, that coordinate the activity of members of the PLC family of enzymes.  These 
interactions occur within the already well characterized context of G protein coupled 
receptor and receptor tyrosine kinase signaling mediated by PLCs.  Pathways involving 
small GTPases and heterotrimeric G proteins both converge on various PLC isozyme 
subfamilies including PLC-β and PLC-ε.  These isozymes therefore function as signaling 
nodes responsible for the integration of signals downstream of a diverse array of cell 
surface receptors.  However, the physiological roles that these two proteins are playing in 
integrating such pathways are not currently understood.  The work presented here has 
provided a beginning to understanding these complex roles by determining the structural 
basis for PLC-β regulation.  The future aims of this research are two fold.  The first is to 
continue to expand the identification and structural characterization of interactions of 
PLC enzymes with their regulators.  The second is to build upon the structural foundation 
established by this work, to develop the tools necessary to dissect the individual 
contributions of such interactions to complex physiological processes.  The first step in 
this process is to make use of the insights gained through the determination of the 
structures of PLC-β2 and PLC-β2 in complex with the small GTPase, Rac1, to ascertain 
the cellular roles of Rac stimulation of PLC-β2 activity.  Despite a current lack of direct 
biological evidence for such a role, a large body of circumstantial evidence suggests a 
unique role of this interaction in mediating the physiological processes of chemotaxis, 
phagocytosis, and superoxide production.  The individual roles of Rac and PLC-β 
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isozymes are well established in these processes79 and both proteins are widely expressed 
in hematopoietic cells.  However, little to no evidence exists for the convergence of these 
roles with the exception of the original discovery of a complex containing these two 
proteins and its subsequent biochemical and structural characterization46.  
 The activation of Rac downstream of G protein coupled receptors activated by 
chemokines plays a firmly established role in the modulation of rearrangements of the 
actin cytoskeleton required to facilitate changes in neutrophil cell polarity, cell migration, 
and phagocytosis80,81.  Expression of constitutively active Rac in the human leukemia cell 
line, HL60, surprisingly eliminates cell polarity82, while expression of dominant negative 
mutants of Rac suppresses chemotaxis83.  The role of Rac in establishing cell polarity is 
so fundamental that it has been described as a chemotactic compass84.  While the effect of 
Rac on changes in cell polarity, chemotaxis, and phagocytosis have been well 
documented, the exact nature of its activation downstream of chemokine receptors 
remains unclear.  One possible mediator of Rac activation is the Gβγ stimulated guanine 
nucleotide exchange factor, P-Rex44,85,86 while another exchange factor shown to mediate 
chemotactic responses in neutrophils is the GEF, Vav187,88.  Whatever the exact 
mechanism of Rac activation turns out to be, the downstream effects of Rac on the actin 
cytoskeleton are known to be mediated by the action of the Wasp/WAVE family of 
proteins and their ability to modulate the activity of the actin remodeling protein, 
Arp2/389.   
 In addition to its essential role in regulating actin dynamics, Rac also mediates the 
cellular bactericidal response involving the generation of superoxide.   Antisense 
oligonucleotides designed to inhibit Rac, dramatically inhibited the superoxide response 
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of B lymphocytes90.  Rac is also required for the targeting of p67phox, an essential 
component of the NADPH oxidase complex and this interaction is dependent on the C-
terminal polybasic region of Rac91.  In fact, expression of Rac was one of the few 
components shown to be required for complete reconstitution of the superoxide burst 
response in a non-hematopoeitic cell line92. 
 While the role of Rac is clearly required for the activation of various cellular 
responses triggered by chemotactic peptides, the function of PLC-β in such processes is 
less clear.  The regulation of phospholipid levels within cells determines the fate of many 
cellular responses including chemotaxis and phagocytosis93.  Therefore, an enzyme such 
as phospholipase C-β, which regulates PtdIns(4,5)P2 levels, would be hypothesized to 
affect these processes.  However, mice lacking the PLC isozymes PLC-β2 and PLC-β3 
showed conflicting results as to their role in chemotaxis94,95.  Bone marrow cells 
harvested from these mice showed no difference in chemotactic response upon exposure 
of the chemoattractant fMLP.  However, they demonstrated statistically significant 
potentiation to chemotaxis in response to interleukin-8 and macrophage inflammatory 
protein-1α95.  This result suggests that PLC-β isozymes act to inhibit chemotactic 
responses and that they may be involved in a negative feedback regulatory loop to govern 
these processes.  This finding was further confirmed by the hyper-migratory responses 
exhibited by neutrophils in the knockout mice, which resulted in severe spontaneous 
facial lesions and an increased innate immune response94.  Surprisingly, pharmacological 
inhibition of PLC-β2 by the compound U73122 showed conflicting results with the 
experiments performed with knockout mice.  U73122 inhibited chemotactic responses 
and acute inflammatory reactions in human neutrophils and canine macrophages, 
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respectively.  However, this inhibitor is known to have various nonspecific properties, 
complicating the interpretation of this data. 
PLC-β2 isozymes were also shown to be essential to the functioning of the 
NADPH superoxide-generating complex in these mice.  Stimulation of superoxide 
production was completely eliminated by genetic deletion of PLC-β295.  In addition, 
recruitment of the vital component of the NADPH complex, p47phox, to the plasma 
membrane was also dramatically reduced indicating that superoxide function was 
inhibited94. 
Through the studies discussed above, roles for both Rac and PLC-β isozymes in 
cellular responses triggered by chemotactic peptides have been firmly established.  
However, links between these two signaling molecules remain poorly characterized.  The 
majority of information concerning these intermolecular connections comes from the 
work identifying and characterizing the interactions between Rac and PLC-β2 as well as 
the structural studies presented here.  An intriguing finding presented here is that 
mutation of residue Phe 37 of Rac results in a GTPase incapable of binding to the PH 
domain of PLC-β2 or stimulating its activity.  This mutation has previously been 
described to affect neutrophil chemotaxis, superoxide production, and myeloid colony 
formation, while retaining other Rac mediated effects96.  This finding supports the 
hypothesis that Rac stimulates PLC-β isozymes to mediate these physiological processes.  
However, because the effects of Rac within cell signaling pathways are diverse, other 
effectors may underlie these events.  Finally, Rac was demonstrated to be responsible for 
the stimulation of PtdIns(4,5)P2 hydrolysis resulting in actin disassembly at the sites of 
phagocytic cups in macrophage cell lines97.  The authors suggested that the mediator of 
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PtdIns(4,5)P2 hydrolysis was indeed PLC-β2, but further experiments are needed to 
confirm this hypothesis. 
To unequivocally determine the cellular role of the interaction the small GTPase, 
Rac1, with its effector, PLC-β2, the signaling network established by this interaction 
must be disrupted by mutagenesis while retaining both functional Rac and PLC-β2 
activity.  The structure described in this work and the accompanying mutagenesis 
provides a tool to achieve such disruption.  Mutation of Gln 52 of the PH domain of PLC-
β2 was demonstrated to dramatically reduce the stimulation of phospholipase activity by 
PLC-β2 upon stimulation by Rac.  However, this mutant retained full stimulation by 
heterotrimeric G protein subunits.  Therefore, targeted mutation of this key interfacial 
residue provides a means of dissecting the cellular function of Rac stimulated PLC-β2 
signaling from that of Gαq or Gβγ.  Knockdown of endogenous PLC-β2 followed by 
transfection of this mutant into a hematopoeitic cell line where PLC-β2 is exclusively 
expressed would therefore identify whether there is a role of this interaction in the 
processes of chemotaxis, phagocytosis, and superoxide production.   Experiments aimed 
at utilizing this mutant to achieve such functional dissection are complicated by the 
expression of PLC-β2 almost exclusively in hematopoeitic cells, which are notoriously 
difficult to transfect and manipulate.  Previous attempts to do so in neutrophil-like (HL-
60) and macrophage-like (TP-1) cells have failed (data not shown). 
 Experiments aimed at circumventing such obstacles are underway using 
neutrophil-like cells derived from the PLC-β2/β3 knockout mice.  Bone marrow will be 
harvested and differentiated to neutrophil-like cells following a protocol previously 
established by Williams, et al96.   Lentiviral constructs, which ensure high rates of 
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infection and expression will be used to reintroduce the PLC-β2 that possesses the Q52A 
mutant.  These experiments will allow for the functional replacement of wild type PLC-
β2 with that containing a mutation capable of disrupting interactions between the enzyme 
and Rac.  The chemotactic, phagocytic, and superoxide responses of these cells will 
therefore elucidate the role of Rac-stimulated PLC-β2 activity in the physiological 
processes of chemotaxis, superoxide production, and phagocytosis. 
 In addition to the experiments outlined above, the dissection of individual 
pathways within complex signaling networks that use PLC isozymes as signaling nodes 
will require the complete identification and characterization of all interacting modulators.  
Structural studies of these binding pairs, such as RhoA and PLC-ε, Rac and PLC-γ2, and 
Gβγ and Gαq with PLC-β2 will greatly advance our understanding of the physiological 
roles of these signaling nodes by providing the tools necessary to dissect their cellular 
roles.  
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